Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Feline tumours share genetic similarities with human cancers
"By comparing cancer genomics across different species, we gain a greater understanding of what causes cancer" - Bailey Francis, Wellcome Sanger Institute.

The discovery could lead to new ways to prevent and treat the disease.

The genetic changes that drive cancer development in domestic cats are comparable to those seen in humans, according to new research. 

The multi-institutional study analysed different tumour types from almost 500 pet cats across five countries and found that certain genetic changes commonly seen in feline cancers mirror those that drive human malignancies. 

For example, the researchers identified that the most common driver gene of feline mammary cancer is similar to the primary driver of human breast cancer, suggesting there are important parallels between the two species. 

It is the first time feline cancer tumours have been profiled at this scale. The work has now been compiled into a freely available resource intended to support future research into feline cancer genomics.

The study was conducted by the Wellcome Sanger Institute, the Ontario Veterinary College in Canada, the University of Bern, and the Cornell University College of Veterinary Medicine. 

Bailey Francis, co-first author at the Wellcome Sanger Institute, said: “By comparing cancer genomics across different species, we gain a greater understanding of what causes cancer. 

“One of our major findings was that the genetic changes in cat cancer are similar to some that are seen in humans and dogs. This could help experts in the veterinary field as well as those studying cancer in humans, showing that when knowledge and data flow between disciplines, we can all benefit.”

Professor Geoffrey Wood, co-senior author at the Ontario Veterinary College, Canada, added: “Despite domestic cats being common pets, there was very little known about the genetics of cancer in these animals until now. 

“Our household pets share the same spaces as us, meaning that they are also exposed to the same environmental factors that we are. This can help us understand more about why cancer develops in cats and humans, how the world around us influences cancer risk, and possibly find new ways to prevent and treat it."

The study, The oncogenome of the domestic cat, is published in Science.

Image (C) Shutterstock/PeopleImages.

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.